Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VCAM1 | P19320 | 11/20 | 1.00 |
| ▸ | MERTK | Q12866 | 2/20 | 0.57 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12253372 | 1.00 | VCAM1 (1.00) | VCAM1MERTKKAT2BMAPTTDP1 | |
| SCHEMBL6387 | 0.85 | VCAM1 (0.74) | VCAM1MERTKKAT2BMAPTTDP1 | |
| SCHEMBL2685395 | 0.85 | VCAM1 (0.73) | VCAM1MERTKTDP1MAPK1 | |
| SCHEMBL698857 | 0.83 | VCAM1 (0.71) | VCAM1MERTKMAPTTDP1MAPK1 | |
| SCHEMBL4477143 | 0.82 | VCAM1 (0.70) | VCAM1MERTKKAT2BMAPTTDP1 | |
| SCHEMBL2683998 | 0.81 | VCAM1 (0.69) | VCAM1MERTKTDP1MAPK1 | |
| SCHEMBL16953440 | 0.81 | VCAM1 (0.69) | VCAM1MERTKTDP1MAPK1 | |
| SCHEMBL17347334 | 0.81 | VCAM1 (0.69) | VCAM1MERTKKAT2BMAPT | |
| SCHEMBL8143514 | 0.79 | VCAM1 (0.66) | VCAM1MERTKKAT2BMAPTTDP1 | |
| SCHEMBL16387399 | 0.79 | VCAM1 (0.66) | VCAM1MERTKKAT2BMAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 677 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111668481-B | Preparation method of metal aluminum secondary battery with multi-group organic micromolecules as positive electrode | 北京科技大学 | 2021-12-03 | — | — | CN | claimed |
| CN-111995545-A | Method for synthesizing 4-chloro-3-nitrobenzonitrile by using microchannel reactor | 成都艾必克医药科技有限公司 | 2020-11-27 | — | — | CN | claimed |
| CN-111668481-A | Preparation method of metal aluminum secondary battery with multi-group organic micromolecules as positive electrode | 北京科技大学 | 2020-09-15 | — | — | CN | claimed |
| CN-110590739-A | Preparation method of erlotinib | 中国药科大学 | 2019-12-20 | — | — | CN | claimed |
| US-9870909-B2 | Compositions and methods for mass spectometry | MSTM, LLC | 2018-01-16 | — | — | US | claimed |
| WO-2014041564-A1 | COVERT SECURITY MARKERS COMPOSITION AND AUTHENTICATION METHOD | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2014-03-20 | — | — | WO | claimed |
| CN-101955464-A | 4-(4-methoxybenzylamino)-3-(5-nitro-4-thiocyanic acid pyrimidine-2-amino) benzonitrile, preparation method and application thereof | TOPHARMAN SHANGHAI CO LTD | 2011-01-26 | — | — | CN | claimed |
| US-6336963-B1 | INK COMPOSITION COMPRISING INK VEHICLE COMPRISING FIRST NITRILE COMPOUND HAVING FIRST VISCOSITY AT MELT TEMPERATURE, VISCOSITY MODIFIER COMPRISING SECOND NITRILE COMPOUND HAVING LOWER VISCOSITY AT MELT TEMPERATURE, COLORANT | XEROX CORPORATION | 2002-01-08 | — | — | US | claimed |
| US-5591378-A | IN COMBINATION WITH PEROXYGEN SOURCE, FORMATION OF PEROXYIMIDIC ACID | THE CLOROX COMPANY (US) | 1997-01-07 | — | — | US | claimed |
| JP-2268147-A | — | — | None | — | — | JP | disclosed |
| EP-4594318-A1 | AKT1 MODULATORS | Alterome Therapeutics, Inc. (US) | 2025-08-06 | — | — | EP | disclosed |
| US-12338226-B2 | Substituted benzodiazoles and use thereof in therapy | THOMAS HELLEDAYS STIFTELSE FOR MEDICINSK FORSKNING (SE) | 2025-06-24 | — | — | US | disclosed |
| CN-120004863-A | ALK protein degradation agent and application thereof in resisting tumor | 江苏天士力帝益药业有限公司 | 2025-05-16 | — | — | CN | disclosed |
| EP-4543863-A1 | FERROPTOSIS INHIBITORS AND USES THEREOF | University Of Ottawa (CA) | 2025-04-30 | — | — | EP | disclosed |
| US-4229459-A | Combating fungi with 1-azol-1-yl-1-phenoxy-2-alkane ethers | BAYER AKTIENGESELLSCHAFT (DE) | 1980-10-21 | — | — | US | disclosed |
| US-4169153-A | PROPHYLAXIS, ANTIHISTAMINES | THE UPJOHN COMPANY (US) | 1979-09-25 | — | — | US | disclosed |
| US-4167569-A | ANTICOAGULANTS | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1979-09-11 | — | — | US | disclosed |
| US-4145342-A | NITRO-DIPHENYLAMINO-AZO-PHENYL DYESTUFFS CONTAINING A POLYALKYENEOXY GROUP | BAYER AKTIENGESELLSCHAFT (DE) | 1979-03-20 | — | — | US | disclosed |
| US-4091011-A | PROPHYLACTIC ANTIANAPHYLACTICS, ANTIALLERGENS | THE UPJOHN COMPANY (US) | 1978-05-23 | — | — | US | disclosed |
| US-3947438-A | Decarbonylation of quinoxalines | PFIZER INC. (US) | 1976-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12338226-B2 | Substituted benzodiazoles and use thereof in therapy | XDH, CYP11B2, CYP4X1 | VCAM1 4153/4885MERTK 2343/4885KAT2B 886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.